QIAGEN OmicSoft and Biomedical Knowledge Base
Investigating biomarkers and drug targets from public data using QIAGEN Omicsoft Diseaseland and QIAGEN Ingenuity Pathway Analysis (IPA)
113 views
In this 90-minute webinar, we’ll cover how to easily query non-oncology public data (GEO, SRA and more) to:
• Rapidly query and identify public datasets that fit our search criteria
• Discover and validate biomarker expression in disease tissue, different treatments and response groups
• Identify a list of biomarkers specific to a condition (non-responders, disease-specific, cell-type specific and more)
• Confirm condition-specific biomarkers through gene expression heatmaps
• Investigate biological mechanisms through network study
• Rapidly query and identify public datasets that fit our search criteria
• Discover and validate biomarker expression in disease tissue, different treatments and response groups
• Identify a list of biomarkers specific to a condition (non-responders, disease-specific, cell-type specific and more)
• Confirm condition-specific biomarkers through gene expression heatmaps
• Investigate biological mechanisms through network study
Related videos
QIAGEN OmicSoft and Biomedical Knowledge Base
Drug treatment, toxicology and target safety assessment using QIAGEN IPA and OmicSoft
In this 90-minute training, you'll learn how to perform drug treatment,...
QIAGEN OmicSoft and Biomedical Knowledge Base
Indication expansion and drug repurposing using QIAGEN OmicSoft and Ingenuity Pathway Analysis
Research and development for new drugs and disease treatments can be lengthy...
QIAGEN OmicSoft and Biomedical Knowledge Base
Target exploration and cell line selection for drug discovery
Cancer cell line models have been a cornerstone of cancer research for...
QIAGEN OmicSoft and Biomedical Knowledge Base
Study of public data on inflammatory conditions public data for biomarker and drug target...
In this 90-minute training on QIAGEN OmicSoft and Ingenuity Pathway Analysis...